Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Florida Medicaid Rx Plan Creates Preferred List, Not Formulary, Court Finds

Executive Summary

The Florida Medicaid supplemental rebate program creates a preferred drug list, not a state Medicaid formulary, Tallahassee, Fla. federal court Judge William Stafford found in upholding the state program

You may also be interested in...



PhRMA vs. Florida

Florida Medicaid preferred drug program upheld by 11th Circuit Court of Appeals in 3-0 decision Sept. 6. Florida program mandates a discount of at least 10% in addition to standard 15% Medicaid rebate for drugs to be included on its preferred list. Pharmaceutical Research & Manufacturers of America filed suit in Tallahassee, Fla. federal court in August 2001, but the lower court determined the program creates a supplemental rebate program, not a Medicaid formulary (1"The Pink Sheet" Jan. 7, p. 29). PhRMA is "considering all options for appeal"...

PhRMA vs. Florida

Florida Medicaid preferred drug program upheld by 11th Circuit Court of Appeals in 3-0 decision Sept. 6. Florida program mandates a discount of at least 10% in addition to standard 15% Medicaid rebate for drugs to be included on its preferred list. Pharmaceutical Research & Manufacturers of America filed suit in Tallahassee, Fla. federal court in August 2001, but the lower court determined the program creates a supplemental rebate program, not a Medicaid formulary (1"The Pink Sheet" Jan. 7, p. 29). PhRMA is "considering all options for appeal"...

Michigan Rx Rebate Program Decision Should Be Left To HHS, DoJ Tells Court

HHS' approval of the Michigan Medicaid supplemental rebate program should be given deference in the Washington, D.C. federal court's review of the program, the Department of Justice said during oral arguments Aug. 28

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039096

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel